PGT Cost in Cyprus 2027: PGT-A, PGT-M, PGT-SR and NGS Guide
PGT cost Cyprus 2027: PGT cost Cyprus 2027 should be viewed as an additional genetic-testing pathway layered onto IVF, not as a standalone test fee. Embryos must first be created, cultured to the appropriate stage, biopsied and usually frozen while the genetics laboratory completes the analysis.
This part can change the total budget and should be clearly stated in the written quotation.
This part can change the total budget and should be clearly stated in the written quotation.
This part can change the total budget and should be clearly stated in the written quotation.
This part can change the total budget and should be clearly stated in the written quotation.
PGT cost Cyprus 2027: How is the cost built?
A genetics quotation should specify the biopsy fee, transport or handling of samples, laboratory analysis, how many embryos are included, whether additional embryos are charged separately, and whether embryo freezing, storage and the later frozen embryo transfer are separate. The IVF cycle itself may be entirely separate.
A complete cost conversation should separate the core treatment from items that depend on response, embryo development or later decisions. This keeps optional technology from being presented as automatically necessary and helps patients see which costs are predictable before treatment and which can only be confirmed during the cycle.
Preimplantation genetic testing
PGT-A evaluates chromosome number, PGT-M targets a known single-gene condition and PGT-SR is used in defined structural chromosome rearrangements. These tests answer different questions and require different preparation. Genetic counselling is especially important when a known inherited condition or parental chromosome finding is involved.
Suitability should be discussed before cost optimisation. A treatment that is inexpensive but poorly matched to the clinical situation can create more time, travel and emotional cost than a plan chosen after reviewing the diagnosis and previous treatment history.
From first review to the next clinical decision
Timing and scope are personalised after review of results and the treatment plan.
Timing and scope are personalised after review of results and the treatment plan.
Timing and scope are personalised after review of results and the treatment plan.
Timing and scope are personalised after review of results and the treatment plan.
Timing and scope are personalised after review of results and the treatment plan.
Timing and scope are personalised after review of results and the treatment plan.
Not every patient follows every step in exactly the same way. The purpose of the pathway is to show where costs and decisions usually arise so that the written plan can be matched to the actual treatment rather than a generic package.
Read the package before you read the price
Commonly part of the core pathway
- Medical review and treatment planning
- Monitoring required by the selected protocol
- Documented laboratory and identity processes
- Procedure or transfer planning
- Patient coordination
Often separate or indication-dependent
- Medication depending on protocol
- PGT or other genetic testing
- Cryopreservation and long-term storage
- Additional laboratory methods when indicated
- Later FET or repeat treatment cycles
- Flights, hotel and local transfers
Medication is one of the most variable cost components. Dose and duration depend on protocol and biological response, so a quote should say whether medicines are included, estimated separately or purchased independently.
Why laboratory scope changes the real cost
The IVF and genetics laboratories form one workflow. Embryos are cultured, suitable blastocysts are biopsied, the biopsy samples are labelled and transferred for genetic analysis, and the embryos are vitrified. Results are later matched back to the correct embryo record before transfer planning.
The useful question is not whether a clinic owns a technology, but whether that technology answers a problem in your case, whether it changes the treatment pathway and whether its price is already included. This approach keeps the plan clinically focused and the cost structure transparent.
Treatment dates and travel dates must be planned together
PGT often changes travel because a fresh transfer is generally not the immediate next step after biopsy. International patients may complete egg retrieval and embryo creation first, return home while results are pending, and then plan a later FET cycle. The exact pathway depends on the test and clinic protocol.
International coordination should provide more than hotel suggestions. It should explain which results can be sent in advance, which monitoring can be performed locally, when the patient needs to be physically in Cyprus and what happens if a biological response shifts the expected date.
A practical checklist for comparing two offers
Compare quotations line by line rather than only by the headline total. Look at the treatment pathway, medications, laboratory methods, any donor or genetic services, freezing, storage and the cost of a later transfer. Also ask which services are only added when medically indicated and what happens financially if timing changes or a cycle cannot proceed as originally planned.
A useful quotation separates what is definitely required, what may reasonably be needed and what is only an optional add-on. That makes it easier to distinguish a low starting price from a genuinely complete treatment budget.
Cost and outcome should not be confused
PGT provides genetic information; it does not guarantee implantation or a healthy live birth. Test limitations, mosaic or inconclusive results, embryo development, uterine factors and pregnancy-related risks still matter. The decision to test should be based on clinical indication and counselling rather than marketing claims.
Whenever you read success statistics, ask which endpoint and population are being reported. Pregnancy per transfer cannot be compared directly with live birth per started cycle. The clinical suitability of the proposed treatment matters more than a single promotional percentage.
For Ventus IVF outcome information, use the dedicated success-rates page and read the denominator and endpoint before comparing percentages.
How to use last year’s market information without creating a false 2027 price
Public 2026 PGT prices often differ because some quote a base biopsy fee while others include a defined number of embryos or the genetics laboratory charge. For 2027, compare the entire chain—biopsy, analysis, freezing, storage and FET—rather than one headline figure.
A 2027 guide should therefore not invent prices that have not been confirmed. It can, however, explain which cost components were visible in public 2026 offers and which items should be checked again in a current personalised quotation.
Better information creates a more accurate quotation
Bring any previous genetic reports, karyotypes, carrier-screening results, family history information and IVF records. For PGT-M, preparation of the family-specific test strategy can take time, so planning should begin before stimulation whenever possible.
The more complete the information before the consultation, the less likely the discussion is to stay at the level of a generic starting price. Previous laboratory reports, genetic results and information about medication or stored embryos can materially change the treatment pathway.
PGT Cost in Cyprus 2027: PGT-A, PGT-M, PGT-SR and NGS Guide — Frequently asked questions
Is PGT included in the IVF price?
Usually not. It often includes separate biopsy, genetics laboratory, embryo freezing and later FET costs.
What is the difference between PGT-A and PGT-M?
PGT-A assesses chromosome number, while PGT-M targets a specific known single-gene condition.
Are embryos frozen after biopsy?
Commonly yes, while genetic results are pending, although exact laboratory practice should be confirmed.
Does PGT guarantee a healthy baby?
No. It reduces or clarifies specific genetic risks within the limits of the test but does not eliminate all pregnancy or health risks.
Why do PGT prices differ by embryo number?
Some laboratories charge a base fee plus a per-embryo analysis fee or include a defined number of samples.
Is genetic counselling useful?
Yes, particularly for PGT-M, PGT-SR, inherited conditions, carrier findings or complex family history.
Review your treatment and cost plan personally
Send your available results and previous treatment history so the team can review the likely pathway and the cost items that may be relevant to you.
Sources and medical review note
This guide is written for general patient information. Individual treatment decisions require medical review, and donor or genetic-treatment rules may vary by jurisdiction.